Health Plans Archives

(800) 975-4819 info@InformedDNA.com
Blog Clinical Health Plans Health Systems Life Sciences Our Take Gemma Nelson M.S., CGC, Genetic Analyst; Alisha Wilkens, M.S., CGC, Operations Analyst \|April 7, 2021April 7, 2021 Clinical Health Plans Health Systems COVID-19’s Impact on Genetic Test Pre-Authorizations Virginia Anne Adams, M.S., CGC, Genetic Analyst; Shanna Gustafson, M.S., CGC, Senior Client Executive\|March 10, 2021March 25, 2021 Clinical Health Plans Health Systems Interpreting variants of uncertain significance (VUS) in larger hereditary cancer panels Jana Pruski-Clark, MPH, MS, CGC, Sr VP, Clinical Services\|February 24, 2021March 25, 2021 Clinical Health Plans Health Systems Life Sciences Genetic Testing: Perception vs. Misconception Kay LeChien, M.S., CGC, Genetic Analyst; Tricia Page, M.S., CGC, Genetic Analyst\|February 11, 2021March 25, 2021 Clinical Health Plans Health Systems Whole Exome Sequencing: How is it being used? David Nixon, Executive Chairman, and Rebecca Sutphen, Co-founder and Chief Medical Officer\|January 29, 2021June 22, 2021 Health Plans Health Systems Life Sciences Our Take Three Genetic Discovery Trends for 2021 David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer\|January 25, 2021January 28, 2021 Health Plans Health Systems Life Sciences Our Take “That’s a wrap!” Our 2020 in Review Heather Dorsey, Evidence Review Manager, M.S., CGC\|January 11, 2021March 25, 2021 Health Plans Life Sciences FDA: Drugs, Devices, and Genetics InformedDNA\|October 15, 2020November 25, 2020 Health Plans The In’s and Out’s of Genetic Testing Payment Integrity Eleanor Riggs, M.S., CGC; Shannon Morrill-Cornelius, M.S., CGC; Chelsea Alexander, M.S., CGC\|September 15, 2020June 3, 2021 Health Plans Our Take Demystifying Medicare Genetic Testing Policies InformedDNA\|July 15, 2020September 1, 2020 Health Plans Complexity of Genetic Testing Affects Payment Integrity for Health Plans 1 2 3 4 Next Let's talk about your genetic services needs. First Name* Last Name* Title Company* Business Email Address* Phone Message By submitting this form, you confirm that your email address may be used to respond to this request and to receive future emails from InformedDNA. CAPTCHA

Gemma Nelson M.S., CGC, Genetic Analyst; Alisha Wilkens, M.S., CGC, Operations Analyst |April 7, 2021April 7, 2021
Clinical Health Plans Health Systems

COVID-19’s Impact on Genetic Test Pre-Authorizations

Virginia Anne Adams, M.S., CGC, Genetic Analyst; Shanna Gustafson, M.S., CGC, Senior Client Executive|March 10, 2021March 25, 2021
Clinical Health Plans Health Systems

Interpreting variants of uncertain significance (VUS) in larger hereditary cancer panels

Jana Pruski-Clark, MPH, MS, CGC, Sr VP, Clinical Services|February 24, 2021March 25, 2021
Clinical Health Plans Health Systems Life Sciences

Genetic Testing: Perception vs. Misconception

Kay LeChien, M.S., CGC, Genetic Analyst; Tricia Page, M.S., CGC, Genetic Analyst|February 11, 2021March 25, 2021
Clinical Health Plans Health Systems

Whole Exome Sequencing: How is it being used?

David Nixon, Executive Chairman, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 29, 2021June 22, 2021
Health Plans Health Systems Life Sciences Our Take

Three Genetic Discovery Trends for 2021

David Nixon, CEO, and Rebecca Sutphen, Co-founder and Chief Medical Officer|January 25, 2021January 28, 2021
Health Plans Health Systems Life Sciences Our Take